Compare IONQ Inc (IONQ) vs Medpace Holdings Inc (MEDP) Price & Performance

IONQ trades at $34.24, down 1.55% on the day amid a broader tech sell-off. The stock is technically bearish with key support at $31, while oscillators suggest potential oversold conditions. Fundamentally, the company shows strong revenue growth projections from $130M in 2025 to $187M in 2026, but remains unprofitable with a net loss of $510M in 2025. Recent news highlights IonQ's leadership in quantum computing but notes significant stock volatility and competitive threats.

The outlook for IonQ is bifurcated: long-term growth potential in quantum computing is substantial, supported by a $73.75 analyst price target, but high valuation multiples and persistent losses pose near-term risks. Investment opportunity hinges on execution of its technology roadmap, while risks include cash burn, competitive pressures, and market sentiment shifts toward speculative tech stocks.

MEDP trades at $527.93, down 1.82% on the day, with a neutral technical signal and mixed oscillators. The stock shows strong profitability with a 17.19% net margin and 77.25% ROE, though valuations are elevated with a P/E of 33.22. Recent quarters have consistently beaten EPS estimates, but a class action lawsuit filed in June 2026 adds uncertainty. Revenue is projected to grow to $2.7B in 2026, while cash flow trends improve from negative to positive net cash flow.

The outlook is cautious due to high valuation and legal overhangs, but fundamental strength in earnings and backlog quality provides support. Analyst consensus is mixed with a $497 price target below current levels, indicating limited near-term upside. Key risks include lawsuit outcomes and competitive pressures in the CRO sector.